EGFL7 promotes immune evasion in glioma through its interaction with integrin β2
Mahajan, S.; Abe, P.; Ehret, F.; Fabian, C.; Heinig, N.; Barth, K.; Gentzel, M.; Gupta, R.; Aprea, J.; Warnke, P.; Wasser, B.; Grabbe, S.; Schmitz, M.; Dahl, A.; Zipp, F.; Schumann, U.; Schmidt, M. H. H.
Show abstract
Glioblastoma is the most aggressive form of malignant brain cancer, characterized by an immunosuppressive microenvironment and extensive angiogenesis. Epidermal growth factor-like protein 7 (EGFL7), a secreted pro-angiogenic factor that is highly expressed in the glioblastoma microenvironment (GME), has been implicated in immune evasion by other solid tumors, but its role in glioblastoma immune regulation remains unclear. Here, we studied the impact of EGFL7 in shaping the immune landscape in glioblastoma and identified underlying mechanisms. Single-cell transcriptomic profiling of immune cells from glioblastoma models revealed that EGFL7 promotes an immunosuppressive GME, characterized by increased infiltration of pro-tumorigenic macrophages and enhanced T cell exhaustion. Mechanistically, EGFL7 interacts with integrin {beta}2 (ITGB2) on immune cells to mediate these effects. Genetic perturbation of the EGFL7-ITGB2 axis attenuated immunosuppression and significantly prolonged the survival of glioblastoma-bearing mice. In conclusion, our study provides unequivocal evidence that the EGFL7-ITGB2 axis acts as a critical mediator of immunosuppression in glioblastoma and represents a potential therapeutic target for reprogramming the GME to prevent immune evasion in glioblastoma.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma 98%
- Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors 96%
- Combinatorial immunotherapies overcome MYC-driven immune evasion 96%
Similar papers in this journal
- MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors 97%
- Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence 96%
- B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling 95%
Similar papers in this journal
Similar papers in this journal
- Cell lineage as a predictor of immune response in neuroblastoma 96%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
- Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.